TY  - JOUR
T1  - GUidelines for treatment of anthrax
AU  - Meyerhoff A, Murphy D
Y1  - 2002/10/16
N1  - 10.1001/jama.288.15.1845
JO  - JAMA
SP  - 1848
EP  - 1849
VL  - 288
IS  - 15
N2  - 
First, Inglesby et al state that there are no US Food and Drug Administration
(FDA)–approved postexposure antibiotic regimens following exposure to
a Bacillus anthracis aerosol. In fact, on August
30, 2000, the FDA approved ciprofloxacin for use in inhalational anthrax (postexposure)
for both adults and children. (Inhalational anthrax postexposure is also referred
to as anthrax postexposure prophylaxis [PEP].)

SN  - 0098-7484
M3  - doi: 10.1001/jama.288.15.1845
UR  - http://dx.doi.org/10.1001/jama.288.15.1845
ER  -